“IN-VITRO EFFICACY OF PIPERACILLIN SULBACTAM AGAINST MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA: A COMPARATIVE STUDY WITH PIPERACILLIN TAZOBACTAM AND CEFOPERAZONE SULBACTAM”. Frontier in Medical and Health Research 4, no. 3 (March 9, 2026): 4971–4977. Accessed November 8, 2026. https://fmhr.net/index.php/fmhr/article/view/3904.